1. Home
  2. MRM vs SNOA Comparison

MRM vs SNOA Comparison

Compare MRM & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIROM Healthcare Technologies Inc.

MRM

MEDIROM Healthcare Technologies Inc.

N/A

Current Price

$0.33

Market Cap

7.6M

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$1.06

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRM
SNOA
Founded
2000
1999
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.1M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
MRM
SNOA
Price
$0.33
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 374.2K
37.7K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
★ N/A
N/A
Revenue
N/A
★ $19,529,000.00
Revenue This Year
N/A
$22.44
Revenue Next Year
N/A
$12.73
P/E Ratio
$32.01
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.25
$0.85
52 Week High
$2.33
$3.95

Technical Indicators

Market Signals
Indicator
MRM
SNOA
Relative Strength Index (RSI) 26.26 38.98
Support Level $0.25 $1.03
Resistance Level $1.34 $1.29
Average True Range (ATR) 0.04 0.07
MACD 0.01 -0.00
Stochastic Oscillator 40.45 22.23

Price Performance

Historical Comparison
MRM
SNOA

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: